探索乳腺癌的瘤微环境,以开发预后模型并预测免疫治疗反应
1Department of Thyroid and Breast Surgery, Wuhan No.1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Scientific reports
|April 12, 2025
概括
这项研究确定了12个预后基因,并开发了一个模型来预测乳腺癌患者的结果和免疫治疗反应. 该模型有助于选择组合免疫疗法和向治疗以提高疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 乳腺癌是女性中普遍存在的恶性瘤,显示出显著的异质性.
- 瘤微环境 (TME) 对癌症进展和治疗反应至关重要,但其在预后和免疫治疗中的作用尚未完全理解.
研究的目的:
- 研究瘤微环境对乳腺癌预后和免疫治疗反应的影响.
- 确定独立的预后基因,并为乳腺癌患者开发预测模型.
主要方法:
- 来自公共数据库的转录组和单细胞测序数据的分析.
- 使用了免疫透分析,共识聚类,WGCNA,Cox和Lasso回归.
- 开发了一个预后模型,并使用TIDE值评估免疫治疗反应.
主要成果:
- 确定了12个独立的预后基因,并构建了一个准确区分高风险和低风险患者的预测模型.
- 该模型表现出强大的预测乳腺癌免疫治疗反应的能力.
- 在内皮细胞比例和患者预后之间发现了显著的关联.
结论:
- 开发的预后模型为个别乳腺癌患者的预后和免疫治疗反应提供了精确的预测.
- 将免疫疗法与通过药物敏感性分析确定的向药物结合使用,可能会提高不响应者治疗的疗效.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


